1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Co-targeting CDK4/6 and AKT with endocrine therapy prevents progression in CDK4/6 inhibitor and endocrine therapy-resistant breast cancer
- Contribution to journal › Article
- 2018
-
Mark
Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
- Contribution to journal › Article
